These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29966154)

  • 1. Thyroid Peroxidase Antibody is Associated with Plasma Homocysteine Levels in Patients with Graves' Disease.
    Li F; Aji G; Wang Y; Lu Z; Ling Y
    Exp Clin Endocrinol Diabetes; 2020 Jan; 128(1):8-14. PubMed ID: 29966154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of antithyroid peroxidase and antiparietal cell antibodies among patients with type 1 diabetes mellitus attending a tertiary diabetes centre in South Africa.
    Paruk IM; Ganie Y; Maharaj S; Pirie FJ; Naidoo VG; Nkwanyana NM; Dinnematin HL; Ramdial PK; Motala AA
    Postgrad Med J; 2017 Jun; 93(1100):338-343. PubMed ID: 27742863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
    Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
    Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quantitative measurement of autoantibodies to thyroglobulin and thyroid peroxidase by automated microparticle based immunoassays in Hashimoto's disease, Graves' disease and a follow-up study on postpartum thyroid disease.
    Gilmour J; Brownlee Y; Foster P; Geekie C; Kelly P; Robertson S; Wade E; Braun HB; Staub U; Michel G; Lazarus JH; Parkes AB
    Clin Lab; 2000; 46(1-2):57-61. PubMed ID: 10745983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.
    Mastorakos G; Doufas AG; Mantzos E; Mantzos J; Koutras DA
    J Endocrinol Invest; 2003 Oct; 26(10):979-84. PubMed ID: 14759070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone autoantibodies in patients with Graves' disease: effect of anti-thyroid drug treatment.
    Ogawa T; Sakata S; Nakamura S; Takuno H; Matsui I; Sarui H; Yasuda K
    Clin Chim Acta; 1994 Aug; 228(2):113-22. PubMed ID: 7988028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin B12 levels are not affected by radioiodine ablation of the thyroid.
    Potham SK; Vaikkakara S; Sachan A; Rao SP; Kalawat TC; Ravi P; Sunil E; Rajitha D; Arun M; Sailaja A
    Endocr Regul; 2014 Apr; 48(2):77-85. PubMed ID: 24824803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of thyroid function, thyroid antibodies and urinary iodine among permanent residents of Urumqi in Xinjiang].
    Wang X; Osiman R; Ma F; Guo Y; Tuhuti H; Zhao H; Abudunaiyimu M; Jin X; Wang H; Xing S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):811-4. PubMed ID: 26714533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF1 deficiency in newly diagnosed Graves' disease patients.
    Martin S; Sirbu A; Betivoiu M; Florea S; Barbu C; Fica S
    Hormones (Athens); 2015; 14(4):651-9. PubMed ID: 26188228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
    Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
    Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
    Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
    J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of microsomal antigen and comparison with histologic localization of HLA-DR in Graves' thyroid tissue.
    Roman SH; Goldsmith NK; Leiderman IZ; Davies TF
    Autoimmunity; 1989; 2(3):253-63. PubMed ID: 2491609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
    Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
    Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
    Chen W; Man N; Li YS; Shan ZY; Teng WP
    Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease.
    Strieder TG; Prummel MF; Tijssen JG; Endert E; Wiersinga WM
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):396-401. PubMed ID: 12919165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
    Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Determination of serum neopterin levels in patients with autoimmune thyroid diseases].
    Balázs C; Türke B; Vámos A
    Orv Hetil; 2012 Jul; 153(29):1127-31. PubMed ID: 22805038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.